Articulatory precision from connected speech as a marker of cognitive decline in Alzheimer’s disease risk-enriched cohorts
Journal of Alzheimer’s Disease · 2025
DOI: 10.1177/13872877241300149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2025. Verfasst von Lingfeng Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Computing and Augmented Intelligence, Arizona State University, Tempe, AZ, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction, Speech. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIDCD NIH HHS, National Institute on Aging.
Themen: Demenz
Abstract (Originalsprache)
Background
Mild cognitive impairment (MCI) has been recognized as a possible precursor to Alzheimer’s disease (AD). Recent research focusing on connected speech has uncovered various features strongly correlated with MCI due to AD and related dementias. Despite these advancements, the impact of early cognitive decline on articulatory precision has not been thoroughly investigated.
Objective
This study introduced the phoneme log-likelihood ratio (PLLR) to assess the articulatory precision of speakers across different cognitive status levels and compared its effectiveness to existing well-studied acoustic features.
Methods
The study utilized speech recordings from a picture description task, which included data from 324 cognitively unimpaired participants with low amyloid-β burden (CU, Aβ( − )), 47 cognitively unimpaired participants with high amyloid-β burden (CU, Aβ( + )), 69 participants with MCI, and 20 participants with dementia. Nine acoustic features were extracted from the speech recordings, covering three categories: speech fluency, speech pace, and articulatory precision. Welch’s t -test and Hedge’s g were adopted to assess their discriminative ability.
Results
A reduction in speech fluency and pace was observed among participants in the MCI and dementia groups. The PLLR shows large effect sizes in distinguishing between cognitively unimpaired participants with low Aβ burden and those diagnosed with MCI or dementia. Additionally, the test-retest reliability experiment indicated moderate repeatability of the features under study.
Conclusions
The study reveals PLLR as a sensitive indicator capable of detecting subtle articulatory variations across groups, while also providing further support for the association between reduced articulatory precision and early cognitive decline.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Computing and Augmented Intelligence, Arizona State University, Tempe, AZ, USA.
- College of Health Solutions, Arizona State University, Tempe, AZ, USA.
- Department of Communication Sciences and Disorders, The University of Wisconsin-Madison, Madison, WI, USA.
- College of Health Solutions, School of Electrical, Computer and Energy Engineering, Arizona State University, Tempe, AZ, USA.
ORCID-Profile: Lingfeng Xu
Förderung
- NIA NIH HHS
- NIDCD NIH HHS
- National Institute on Aging
- John and Tami Marick Family Foundation
Zitieren
APA
Xu, L., Chen, K., Mueller, K. D., Liss, J., & Berisha, V. (2025). Articulatory precision from connected speech as a marker of cognitive decline in Alzheimer’s disease risk-enriched cohorts. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877241300149
Vancouver
Xu L, Chen K, Mueller KD, Liss J, Berisha V. Articulatory precision from connected speech as a marker of cognitive decline in Alzheimer’s disease risk-enriched cohorts. Journal of Alzheimer’s Disease. 2025. doi:10.1177/13872877241300149
BibTeX
@article{Xu2025,
author = {Xu, Lingfeng and Chen, Kewei and Mueller, Kimberly D and Liss, Julie and Berisha, Visar},
title = {Articulatory precision from connected speech as a marker of cognitive decline in Alzheimer’s disease risk-enriched cohorts},
journal = {Journal of Alzheimer’s Disease},
year = {2025},
doi = {10.1177/13872877241300149}
}
EUVIMED